[1]钱　琪,韩　凯,冯　陆.急性脑梗死合并2型糖尿病患者时间窗内行血管内介入治疗的预后影响因素[J].新乡医学院学报,2022,39(6):528-532.[doi:10.7683/xxyxyxb.2022.06.006]
　QIAN Qi,HAN Kai,FENG Lu.Prognostic factors of patients with acute cerebral infarction and type 2 diabetes mellitus undergoing endovascular interventional therapy within the time window[J].Journal of Xinxiang Medical University,2022,39(6):528-532.[doi:10.7683/xxyxyxb.2022.06.006]
点击复制

急性脑梗死合并2型糖尿病患者时间窗内行血管内介入治疗的预后影响因素
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年6
页码:
528-532
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Prognostic factors of patients with acute cerebral infarction and type 2 diabetes mellitus undergoing endovascular interventional therapy within the time window
作者:
钱　琪; 韩　凯; 冯　陆
（焦作市人民医院神经内科，河南　焦作　454150）
Author(s):
QIAN Qi; HAN Kai; FENG Lu
（Department of Neurology,Jiaozuo People′s Hospital，Jiaozuo 454150,Henan Province,China）
关键词:
急性脑梗死; 2型糖尿病; 血管内介入治疗; 预后
Keywords:
acute cerebral infarction; type 2 diabetes mellitus; endovascular interventional therapy; prognosis
分类号:
R743
DOI:
10.7683/xxyxyxb.2022.06.006
文献标志码:
A
摘要:
目的　探讨急性脑梗死合并2型糖尿病（T2DM）患者时间窗内行血管介入治疗的预后影响因素。方法　选择2016年9月至2019年9月焦作市人民医院神经内科收治的100例急性脑梗死合并T2DM患者为研究对象。患者均于时间窗内行血管介入治疗，术后随访90 d（失访2例），根据改良Rankin量表评分（mRS）将患者分为预后不良组（mRS≥4分，n=38）和预后良好组（mRS<4分，n=60）。采用单因素及多因素logistic回归分析影响患者预后的因素。结果　98例患者中预后不良发生率为38.78%（38/98）。年龄≥60岁、T2DM病程、术前美国国立卫生研究院卒中量表(NIHSS)评分、基底动脉梗死、糖化血红蛋白（HbAlc）是影响急性脑梗死合并T2DM患者时间窗内行血管介入治疗预后的因素（P<0.05）；性别、体质量指数、高血压史、冠状动脉性心脏病史、高脂血症史、吸烟史、酗酒史、股动脉穿刺至血管再通时间、介入治疗方式及随机血糖、三酰甘油、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、C反应蛋白水平与急性脑梗死合并T2DM患者时间窗内行血管介入治疗的预后无关（P>0.05）。Logistic回归分析结果显示，HbAlc、术前NIHSS评分、T2DM病程、基底动脉梗死是影响急性脑梗死合并T2DM患者时间窗内行血管介入治疗预后的独立因素（P<0.05）。结论　急性脑梗死合并T2DM患者在时间窗内行血管内介入治疗预后不良发生率仍较高，NIHSS评分、HbAlc、T2DM病程及基底动脉梗死是影响患者预后的因素。
Abstract:
Objective　To investigate the prognostic factors of patients with acute cerebral infarction combined with type 2 diabetes mellitus (T2DM) undergoing the endovascular interventional therapy within the time window.Methods　A total of 100 patients with acute cerebral infarction combined with T2DM who were treated in the Department of Neurology of Jiaozuo People′s Hospital from September 2016 to September 2019 were selected as the research objects.All patients underwent endovascular interventional therapy within the time window.They were followed up for 90 days after operation.Two patients were lost to follow-up.The patients were divided into poor prognosis group［modified Rankin scale score（mRS)≥4，n=38］ and good prognosis group（mRS<4，n=60） according to the modified mRS.Univariate and multivariate logistic regression were used to analyze the factors influencing the prognosis of patients.Results　In the 98 patients,the incidence of poor prognosis was 38.78% (38/ 98).The age ≥60 years old,the duration of T2DM，the preoperative National Institutes of Health stroke scale（NIHSS） score，basilar artery infarction and glycosylated hemoglobin A1C（HbAlc） level were the factors influencing the prognosis of patients with acute cerebral infarction combined with T2DM who underwent endovascular interventional therapy within the time window(P<0.05);the gender,body mass index,history of hypertension,history of coronary heart disease,history of hyperlipidemia,history of smoking,history of alcoholism,the time from femoral artery puncture to vascular recanalization,the mode of interventional therapy and the levels of random blood glucose,triacylglycerol,total cholesterol,low density lipoprotein-cholesterol,high density lipoprotein-cholesterol and C-reactive protein were not associated with the prognosis of patients with acute cerebral infarction combined with T2DM who underwent endovascular interventional therapy within the time window (P>0.05).Logistic regression analysis showed that HbAlc,preoperative NIHSS score,the duration of T2DM and basilar artery infarction were independent factors influencing the prognosis of patients with acute cerebral infarction combined with T2DM who underwent endovascular interventional therapy within the time window(P<0.05).Conclusion　The incidence of poor prognosis of patients with acute cerebral infarction combined with T2DM who undergo the endovascular interventional therapy within the time window is still high.The NIHSS score,HbAlc level,duration of T2DM and basilar artery infarction are factors influencing the prognosis of patients.

参考文献/References:

［1］　SUN Z,XU Q,GAO G,et al.Clinical observation in edaravone treatment for acute cerebral infarction［J］.Niger J Clin Pract,2019,22(10):1324-1327.
［2］　SHIBATA K,HASHIMOTO T,MIYAZAKI T,et al.Thrombolytic therapy for acute ischemic stroke:past and future［J］.Curr Pharm Des,2019,25(3):242-250.
［3］　TAKAMIYA Y,OKAMURA K,SHIRAI K,et al.Multicenter prospective observational study of teneligliptin,a selective dipeptidyl peptidase-4 inhibitor,in patients with poorly controlled type 2 diabetes:focus on glycemic control,hypotensive effect,and safety Chikushi Anti-Diabetes Mellitus Trial-Teneligliptin(CHAT-T)［J］.Clin Exp Hypertens,2020,42(3):197-204.
［4］　刘新峰,刘锐.脑梗死急性期的血管内介入诊疗［J］.中华神经科杂志,2020,53(5):372-375.
LIU X F,LIU R.Endovascular treatment for acute ischemic stroke［J］. Chin J Neurol, 2020,53(5):372-375
［5］　中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)［J］.中国实用内科杂志,2018,38(4):292-344.
DIABETES BRANCH OF CHINESE MEDICAL ASSOCIATION.Reaction to guideline for the prevention and treatment of type 2 diabetes mellitus in China (2017 edition)［J］.Chin J Diabetes Mellitus,2018,38(4):292-344.
［6］　饶明俐.中国脑血管病防治指南:试行版［M］.北京：人民卫生出版社,2007:15-18.
RAO M L.Chinese guidelines for prevention and treatment of cerebrovascular diseases:trial version［M］.Beijing：People′s Health Publishing House,2007:15-18.
［7］　中华医学会神经病学分会,中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南［J］.中华神经科杂志,2015,48(5):356-361.
NEUROLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION,NEUROVASCULAR INTERVENTION COOPERATION GROUP OF NEUROLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION,AND INTERVENTIONAL DIAGNOSIS AND TREATMENT GUIDE WRITING GROUP OF ACUTE ISCHEMIC STROKE.Chinese guidelines for the endovascular treatment of acute ischemic stroke［J］.Chin J Neurol,2015,48(5):356-361.
［8］　LEE S Y,KIM D Y,SOHN M K,et al.Determining the cut-off score for the modified Barthel index and the modified Rankin scale for assessment of functional independence and residual disability after stroke［J］.PLoS One,2020,15(1):e0226324.
［9］　HAN J Q,LIU C L,WANG Z Y,et al.Anti-inflammatory properties of lipoxin A4 protect against diabetes mellitus complicated by focal cerebral ischemia/reperfusion injury［J］.Neural Regen Res,2016,11(4):636-640.
［10］　HILLMAN T C,MATEI N,TANG J,et al.Developing a standardized system of exposure and intervention endpoints for isoflurane in preclinical stroke models［J］.Med Gas Res,2019,9(1):46-51.
［11］　何超,徐翀,李远超.急性基底动脉闭塞血管内介入治疗的疗效及预后不良的危险因素［J］.中国临床神经外科杂志,2019,24(7):399-401.
HE C,XU C,LI Y C.Efficacy and risk factors of poor prognosis of intravascular interventional therapy for acute basilar artery occlusion［J］.Chin J Clin Neurosurg,2019,24(7):399-401.
［12］　王岩,张雪芳,李杰,等.急性缺血性脑卒中静脉溶栓治疗预后的影响因素［J］.中国老年学杂志,2018,38(15):3597-3600.
WANG Y,ZHANG X F,LI J,et al.Prognostic factors of intravenous thrombolytic therapy for acute ischemic stroke［J］.Chin J Gerontol,2018,38(15):3597-3600.
［13］　CHALOS V,VAN DER ENDE N A M,LINGSMA H F,et al.National institutes of health stroke scale:an alternative primary outcome measure for trials of acute treatment for ischemic stroke［J］.Stroke,2020,51(1):282-290.
［14］　TAM D.Calculated decisions:Pediatric National Institutes of Health Stroke Scale (Ped NIHSS)［J］.Pediatr Emerg Med Pract,2019,16(11):CD1-CD2.
［15］　李青松,陈珑,刘一之,等.动脉内机械取栓治疗急性后循环缺血性脑卒中临床效果及预后影响因素［J］.中国介入影像与治疗学,2019,16(6):333-337.
LI Q S,CHEN L,LIU Y Z,et al.Clinical efficacy and prognostic factors of mechanical thrombectomy in treatment of acute posterior circulation ischemic stroke［J］.Chin J Interv Imaging Ther,2019,16(6):333-337.
［16］　JIANG Z,WANG J,ZHAO P,et al.HbA1c:high in acute cerebral infarction and low in brain trauma［J］.Prog Mol Biol Transl Sci,2019,162:293-306.
［17］　吴琼,赵明,赵荟,等.节段性中重度基底动脉狭窄与后循环缺血性脑卒中的相关性研究［J］.哈尔滨医科大学学报,2019,255(3):68-72.
WU Q,ZHAO M,ZHAO H,et al.Correlation between segmental moderate and severe basilar artery stenosis and posterior circulation ischemic stroke［J］.J Harbin Med Univ,2019,255(3):68-72.

相似文献/References:

[1]何茶叶,刘 平,焦新彩,等.灯盏花素治疗急性脑梗死30例疗效观察[J].新乡医学院学报,2001,18(06):425.
[2]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[3]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]高连英,罗开国.降纤酶治疗急性脑梗死50例[J].新乡医学院学报,2003,20(02):143.
[6]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[7]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[8]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[9]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[10]陈娟,姬明丽.急性脑梗死患者血糖水平与梗死范围及预后的关系 [J].新乡医学院学报,2006,23(03):000.
[11]付　彦.2型糖尿病合并急性脑梗死患者颈动脉粥样硬化及血清脂联素、可溶性细胞间黏附分子-1和可溶性血管细胞间黏附分子-1水平分析[J].新乡医学院学报,2020,37(7):674.[doi:10.7683/xxyxyxb.2020.07.018]
　FU Yan.Analysis of carotid atherosclerosis and the levels of serum adiponectin,soluble intercellular adhesion molecule-1 and soluble vascular cell adhesionmolecula-1 in patients with type 2 diabetes mellitus complicated with acute cerebral infarction[J].Journal of Xinxiang Medical University,2020,37(6):674.[doi:10.7683/xxyxyxb.2020.07.018]

更新日期/Last Update: 2022-06-05